| Issue 1038: February 5, 2013 TOP STORIES
IAC HANDOUTS FEATURED RESOURCES
JOURNAL ARTICLES AND NEWSLETTERS
EDUCATION AND TRAINING
CONFERENCES AND MEETINGS
TOP STORIES Reminder: IAC launched a major redesign of www.vaccineinformation.org, its website for the public We have completed a major transformation of our website for the public, www.vaccineinformation.org, making it one of the most comprehensive and user-friendly sources of scientifically accurate and easily navigable immunization information on the Web today. Visitors to the website can now easily find what they need, whether they are looking for information on a particular vaccine or on vaccines needed by a particular age group, personal stories or video clips, or other resources, such as those from CDC and state health departments. Titled “Vaccine Information You Need,” the website offers parents, other adults, legislators, the media, and all interested Web users a one-stop shop for learning about vaccines and their importance. Information on the website is organized into sections based on the four age groups listed below. This arrangement allows visitors to easily find vaccine schedules and other information pertinent to people of a specific age: Highlights of Vaccineinformation.org
If you have a website, blog, or Facebook page, please link to www.vaccineinformation.org. Back to top FDA approves expanded age indication for use of Prevnar 13 to include children and teens age 6 through 17 years On January 25, FDA approved the use of Prevnar 13, the pneumococcal 13-valent conjugate vaccine (PCV13; Pfizer Inc.), for prevention of invasive pneumococcal disease in children and adolescents age 6 through 17 years caused by serotypes contained in the vaccine. Prevnar 13 was originally approved on February 24, 2010, for use in infants and children age 6 weeks through 5 years. On December 30, 2011, FDA approved expanding the age indication for use of Prevnar to include people age 50 and older. Related Links
CDC holds press telebriefing on U.S. adult vaccination rates On January 29, CDC held a media telebriefing titled U.S. Adult Vaccination Rates. The presenters were Howard Koh, MD, MPH, assistant secretary for health, Department of Health and Human Services, and Carolyn Bridges, MD, associate director of adult immunizations, Immunization Services Division, NCIRD. Resources for clinicians
CDC publishes report on noninfluenza vaccination coverage among U.S. adults in 2011 CDC published Noninfluenza Vaccination Coverage Among Adults—United States, 2011 in the February 1 issue of MMWR (pages 66–72). This report was previously published as an MMWR Early Release on January 29, and was previously covered in the January 29 IAC Express. Back to top Clinicians: The Influenza Vaccine Availability Tracking System (IVATS) can help you find influenza vaccine The National Influenza Vaccine Summit regularly posts updated information to the Influenza Vaccine Availability Tracking System (IVATS). A resource for healthcare settings looking to purchase influenza vaccine, IVATS contains information from approved, enrolled, and participating wholesale vaccine distributors or manufacturers of U.S. licensed influenza vaccine. Ongoing updates are being made and will continue to be made throughout the 2012–13 influenza vaccination season. Keep checking back. Back to top IAC HANDOUTS IAC updates its staff-education piece "Pneumococcal Vaccines—CDC answers your questions" IAC recently made one change to the staff-education piece Pneumococcal Vaccines—CDC answers your questions. The answer to the question summarizing the revaccination recommendations for PPSV23 has been completely rewritten to provide more clarity. IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely. Back to top FEATURED RESOURCES Influenza continues to spread and is serious; vaccination is recommended for nearly everyone, so please keep vaccinating your patients CDC's recent reports indicate overall elevated influenza activity. Reprinted below is the Key Flu Indicators section of CDC's Summary of Weekly FluView for the week ending January 26. According to the latest FluView report, while influenza activity remains elevated overall, it is decreasing in parts of the country but increasing in others. In particular, flu activity is declining in the East and increasing in the West of the country. Key indicators reflecting severity, such as hospitalizations and deaths, remain significantly elevated again this week, with the greatest impact occurring among people 65 and older. [IAC Express editor's note: For additional FluView information, see the last entry in the bulleted list below.] Vaccination remains the single most effective means of preventing influenza. Vaccination is recommended for everyone age 6 months and older, so please continue to vaccinate your patients. If you don't provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to the HealthMap Vaccine Finder to locate sites near their workplaces or homes that offer influenza vaccination services. If you are seeking influenza vaccine for your clinic, check the Influenza Vaccine Availability Tracking System (IVATS), which is a resource for healthcare settings looking to purchase influenza vaccine. The IVATS chart contains information from approved, enrolled, and participating wholesale vaccine distributors or manufacturers of U.S. licensed influenza vaccine. Information is updated on an ongoing basis. Following is a list of resources related to influenza disease and vaccination for healthcare professionals and the public.
Infographic shows parents how the effectiveness and safety of childhood vaccines are ensured CDC recently developed an infographic titled The Journey of Your Child's Vaccine. Using words and pictures, it gives parents detailed information on the following:
Back to top CDC's newly launched Tetanus web section offers information for professionals and the public Launched in January, CDC's Tetanus web section offers healthcare professionals and the public comprehensive information. Here are links to major topics: The Tetanus web section home page also offers the public information on symptoms and tetanus vaccination (what you need to know, vaccine basics, vaccine safety, and school mandates). Back to top JOURNAL ARTICLES AND NEWSLETTERS January issue of CDC's Immunization Works newsletter now available CDC recently released the January issue of its monthly newsletter Immunization Works and posted it on the website of the National Center for Immunization and Respiratory Diseases (NCIRD). The newsletter offers the immunization community information about current topics. The information is in the public domain and can be reproduced and circulated widely. The January issue contains a great deal of useful, timely information. Be sure to read through all three sections: News and Summaries; Influenza Information; and Meetings, Conferences, and Resources. Of particular note, the Meeting, Conferences, and Resources section provides links to the following resources:
CDC's QuickStats shows percentage of adults age ≥65 years who ever received pneumococcal vaccine by race/ethnicity CDC published QuickStats: Percentage of Adults Aged ≥65 Years Who Had Ever Received a Pneumococcal Vaccination, by Selected Race/Ethnicity—National Health Interview Survey, United States, 2000–2011 in the February 1 issue of MMWR (page 75). The figure shows pneumococcal vaccination percentages for white, non-Hispanic; black, non-Hispanic; and Hispanic U.S. adults age 65 and older during the years 2000–2011. The section titled "Alternate Text" is reprinted below. The figure above shows the percentage of adults aged ≥65 years who had ever received a pneumococcal vaccination, by selected race/ethnicity, in the United States during 2000-2011. The percentage of adults aged ≥65 years who had ever received a pneumococcal vaccination increased from 56.8% in 2000 to 66.5% in 2011 among non-Hispanic whites, from 30.5% in 2000 to 47.6% in 2011 among non-Hispanic blacks, and from 30.4% in 2000 to 43.1% in 2011 among Hispanics. Throughout 2000-2011, the percentage who had ever received a pneumococcal vaccination was higher among non-Hispanic white adults aged ≥65 years than among Hispanics and non-Hispanic blacks. Back to top EDUCATION AND TRAINING February 13 webinar to present CDC's promotional resources for 2013 National Infant Immunization Week April 20–27 is 2013 National Infant Immunization Week (NIIW). CDC has developed many materials that health departments and others can use to promote NIIW in their communities. CDC will introduce the materials to interested healthcare personnel through a webinar, which is scheduled for February 13 at 1 p.m. ET. Information on other time zones and languages is available. Use the online registration form to sign up (registration is required). Online help is available (click on "support" in the left column), as is email assistance. Back to top CDC schedules February 19 webinar on reducing HPV-related cancers through vaccination A CDC Public Health Grand Rounds webinar titled Reducing the Burden of HPV-associated Cancer and Disease through Vaccination in the U.S. will be held February 19 at 1 p.m. ET. An archived version of the session will be posted to the Grand Rounds Archive Page within 48–72 hours after the original session is held. Free continuing education credit is available. Back to top CONFERENCES AND MEETINGS Important: CDC postpones 46th National Immunization Conference until spring 2014 CDC recently announced that the 46th National Immunization Conference (NIC), originally scheduled for June 3–6, 2013, has been postponed until spring 2014. In a message to grantees, CDC stated the following: Unexpected logistic challenges made it impossible to provide the high quality conference that we have all come to expect so we made the decision to postpone NIC. CDC recognizes the value of NIC and is already engaged in planning for 2014. We will provide the specific dates for the Spring 2014 NIC as soon as we have them. As we have additional information on the 2014 conference, we will post it on the conference web page and make everyone aware of it. IAC Express will inform readers about CDC's plans for the 2014 NIC as they develop. Back to top Conference on Options for the Control of Influenza planned for September 5–10 in Cape Town, South Africa An international scientific conference focused on influenza, Options for Control of Influenza VIII will be held on September 5–10 in Cape Town, South Africa. The deadline for abstract submissions is June 3. Early bird registration ends on February 14. Many online registration options are available. Back to top  |
About IZ Express
IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
ISSN 2771-8085
IZ Express Disclaimer
ISSN 2771-8085
Editorial Information
-
Editor-in-ChiefKelly L. Moore, MD, MPH
-
Managing EditorJohn D. Grabenstein, RPh, PhD
-
Associate EditorSharon G. Humiston, MD, MPH
-
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA -
Style and Copy EditorMarian Deegan, JD
-
Web Edition ManagersArkady Shakhnovich
Jermaine Royes -
Contributing WriterLaurel H. Wood, MPA
-
Technical ReviewerKayla Ohlde